Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

Nature Genetics

Volumn 41, Issue 4, 2009, Pages 465-472

  Northcott, Paul A ^a,b,c   Nakahara, Yukiko ^a,b   Wu, Xiaochong ^a,b   Feuk, Lars ^c,d   Ellison, David W ^e   Croul, Sid ^f   Mack, Stephen ^a,b,c   Kongkham, Paul N ^a,c   Peacock, John ^a,b   Dubuc, Adrian ^a,b,c   Ra, Young Shin ^a   Zilberberg, Karen ^a,b,c   Mcleod, Jessica ^a,b   Scherer, Stephen W ^c,d   Sunil Rao, J ^g   Eberhart, Charles G ^h   Grajkowska, Wiesia ⁱ   Gillespie, Yancey ^j   Lach, Boleslaw ^k   Grundy, Richard ^l   Pollack, Ian F ^m   Hamilton, Ronald L ^m   Van Meter, Timothy ⁿ   Carlotti, Carlos G ^o   Boop, Frederick ^e   Bigner, Darrell ^p   Gilbertson, Richard J ^e   Rutka, James T ^a,c   Taylor, Michael D ^a,b,c   more..

^a Division of Neurosurgery

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^j Kentucky   (United States)

^k MCMASTER UNIVERSITY   (Canada)

^l UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^m CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

ⁿ VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF SÃO PAULO   (Brazil)

^p DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; LYSINE;

ARTICLE; BLOCKING FACTOR; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; GENETIC DATABASE; HEREDITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MEDULLOBLASTOMA; METHYLATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; READING; STEM CELL; WRITING;

CEREBELLAR NEOPLASMS; GENE AMPLIFICATION; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LYSINE; MEDULLOBLASTOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE DELETION;

EID: 63449115501     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.336     Document Type: Article

References (30)

1. Marino, S. Medulloblastoma: developmental mechanisms out of control. Trends Mol. Med. 11, 17-22 (2005).
2. Reardon, D.A. et al. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res. 57, 4042-4047 (1997).
3. Bayani, J. et al. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J. Neurosurg. 93, 437-448 (2000).
4. Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. USA 104, 20007-20012 (2007).
5. Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D.M. & Nakatani, Y. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296, 1132-1136 (2002).
6. Klymenko, T. et al. A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities. Genes Dev. 20, 1110-1122 (2006).
7. Mullighan, C.G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758-764 (2007).
8. Weir, B.A. et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898 (2007).
9. Cloos, P.A. et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442, 307-311 (2006).
10. Shin, S. & Janknecht, R. Diversity within the JMJD2 histone demethylase family. Biochem. Biophys. Res. Commun. 353, 973-977 (2007).
11. Shi, Y. et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422, 735-738 (2003).
12. Fodor, B.D. et al. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev. 20, 1557-1562 (2006).
13. Howe, L. et al. Histone H3 specific acetyltransferases are essential for cell cycle progression. Genes Dev. 15, 3144-3154 (2001).
14. Lu, J., Ruhf, M.L., Perrimon, N. & Leder, P. A genome-wide RNA interference screen identifies putative chromatin regulators essential for E2F repression. Proc. Natl. Acad. Sci. USA 104, 9381-9386 (2007).
15. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J. & Berns, A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994-1004 (2000).
16. Olson, M.V. et al. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 67, 4005-4009 (2007).
17. Kenney, A.M., Cole, M.D. & Rowitch, D.H. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 130, 15-28 (2003).
18. Knoepfler, P.S., Cheng, P.F. & Eisenman, R.N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16, 2699-2712 (2002).
19. Marino, S., Hoogervoorst, D., Brandner, S. & Berns, A. Rb and p107 are required for normal cerebellar development and granule cell survival but not for Purkinje cell persistence. Development 130, 3359-3368 (2003).
20. Gateff, E., Loffler, T. & Wismar, J. A temperature-sensitive brain tumor suppressor mutation of Drosophila melanogaster: developmental studies and molecular localization of the gene. Mech. Dev. 41, 15-31 (1993).
21. Trimarchi, J.M., Fairchild, B., Wen, J. & Lees, J.A. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl. Acad. Sci. USA 98, 1519-1524 (2001).
22. Leung, C. et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428, 337-341 (2004).
23. Wiederschain, D. et al. Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. Mol. Cell. Biol. 27, 4968-4979 (2007).
24. Cartwright, P., Muller, H., Wagener, C., Holm, K. & Helin, K. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 17, 611-623 (1998).
25. Panteleeva, I. et al. HP1alpha guides neuronal fate by timing E2F-targeted genes silencing during terminal differentiation. EMBO J. 26, 3616-3628 (2007).
26. Thomas, T. et al. Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells. Genes Dev. 20, 1175-1186 (2006).
27. Annunziata, C.M. et al. Frequent engagement of the classical and alternative NFkappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115-130 (2007).
28. Romer, J.T. et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 6, 229-240 (2004).
29. Kubicek, S. et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell 25, 473-481 (2007).
30. Thompson, M.C. et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J. Clin. Oncol. 24, 1924-1931 (2006).